InvestorsHub Logo
icon url

bwolfy2002

12/14/20 11:03 PM

#133532 RE: Badge04 #133529

I’m not disagreeing. I’m saying that if there had to be full on BLA submission and approval. That in a worst case, that timeline without fast track could go a lot longer in the US.

That whole shindig will not occur because somewhere Lero will be being sold very soon and that’s all that matters to this story: revenue.
icon url

Amatuer17

12/15/20 6:40 AM

#133544 RE: Badge04 #133529

Have you seen this study by RedHill - well it is not as well discussed like Lero but the study is going very well and they will compete with CYDY as their mgmt is better than NP

https://abc11.com/covid-medicine-to-treat-opaganib-redhill/8690517